Your browser doesn't support javascript.
Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar; Abraham, George M; Jokela, Janet A; Miller, Matthew C; Forciea, Mary Ann; Humphrey, Linda L; Dunn, Andrew; Andrews, Rebecca; Haeme, Ray; Tschanz, Mark P.
  • Qaseem A; American College of Physicians, Philadelphia, Pennsylvania.
  • Yost J; Villanova University, Villanova, Pennsylvania.
  • Etxeandia-Ikobaltzeta I; American College of Physicians, Philadelphia, Pennsylvania.
  • Abraham GM; Saint Vincent Hospital-Worcester Medical Center, Worcester, Massachusetts.
  • Jokela JA; University of Illinois College of Medicine at Urbana-Champaign, Champaign, Illinois.
  • Miller MC; Penn Medicine Radnor, Radnor, Pennsylvania.
  • Forciea MA; Penn Medicine, Philadelphia, Pennsylvania.
  • Humphrey LL; Portland Veterans Affairs Medical Center and Oregon Health & Science University, Portland, Oregon.
Ann Intern Med ; 174(9): W66-W67, 2021 09.
Article in English | MEDLINE | ID: covidwho-1305873
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / COVID-19 Drug Treatment Limits: Humans Country/Region as subject: North America Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physicians / COVID-19 Drug Treatment Limits: Humans Country/Region as subject: North America Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article